Screener
Spero Therapeutics, Inc. SPRO Q2 2025 earnings
Reported August 12, 2025 · After market close
Revenue$11.8MBeat by $802.0K
EPS-$0.03Beat by $0.35
Revenue estimate$11.0M
EPS estimate-$0.38
Next report
Nov 12, 2026 (in 2 months)EPS estimate-$0.14
Versus estimates
Revenue
Q1 2026$258.0KIn lineQ4 2025$41.3MBeat by $15.3MQ3 2025$3.0MMiss by $9.0M
Q2 2025$11.8MBeat by $802.0K
Q1 2025$5.9MMiss by $5.1MDiluted EPS
FAQ
- When did Spero Therapeutics, Inc. report Q2 2025 earnings?
- Spero Therapeutics, Inc. (SPRO) reported Q2 2025 earnings on August 12, 2025 after market close.
- What were Spero Therapeutics, Inc.'s Q2 2025 revenue and EPS?
- Spero Therapeutics, Inc. reported revenue of $11.8M and eps of $-0.03 for Q2 2025.
- Did Spero Therapeutics, Inc. beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $11.0M by $802.0K. EPS beat the consensus estimate of $-0.38 by $0.35.
- How did Spero Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 96.1% from $6.0M a year earlier and eps grew 90.9% from $-0.33.
- Where can I find Spero Therapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-25-178970) and the 10-Q periodic report (0000950170-25-107388) directly on SEC EDGAR. The filing index links above go to sec.gov.
